300199.SZ
Price:
$18.75
Market Cap:
$16.56B
Hybio Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of therapeutic peptides API and polypeptide drugs in China and internationally. The company provides liraglutide, semaglutide and exenatide for diabetes; terlipressin, desmopressin and linaclotide for digestive tract and metabolic system; ganirelix, cetrorelix and atosiban for obstetrics and gynecology, etc; customized peptides; working standards for the peptide APIs and related impurities, to facilitate your project in an all-round way; CRO services; and platform for CDMO services, which includes peptide API synthesis and purification process development, finish dosage form development, reference s...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-04-07
Stock Exchange
SHZ
Ticker
300199.SZ
According to Hybio Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.35B. This represents a change of 14.44% compared to the average of 16.04B of the last 4 quarters.
The mean historical Enterprise Value of Hybio Pharmaceutical Co., Ltd. over the last ten years is 13.08B. The current 18.35B Enterprise Value has changed 13.93% with respect to the historical average. Over the past ten years (40 quarters), 300199.SZ's Enterprise Value was at its highest in in the December 2015 quarter at 24.41B. The Enterprise Value was at its lowest in in the March 2021 quarter at 5.58B.
Average
13.08B
Median
13.18B
Minimum
6.33B
Maximum
22.43B
Discovering the peaks and valleys of Hybio Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.90%
Maximum Annual Enterprise Value = 22.43B
Minimum Annual Increase = -43.42%
Minimum Annual Enterprise Value = 6.33B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 12.60B | -7.19% |
| 2023 | 13.57B | -21.17% |
| 2022 | 17.22B | 34.69% |
| 2021 | 12.78B | 73.52% |
| 2020 | 7.37B | 16.42% |
| 2019 | 6.33B | -24.06% |
| 2018 | 8.33B | -43.42% |
| 2017 | 14.73B | -4.62% |
| 2016 | 15.44B | -31.15% |
| 2015 | 22.43B | 91.90% |
The current Enterprise Value of Hybio Pharmaceutical Co., Ltd. (300199.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
14.46B
5-year avg
12.71B
10-year avg
13.08B
Hybio Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Shenzhen Kangtai Biological Products Co., Ltd. (17.92B), greater than Fujian Cosunter Pharmaceutical Co., Ltd. (14.46B), greater than China Resources Double-Crane Pharmaceutical Co.,Ltd. (18.13B), greater than Walvax Biotechnology Co., Ltd. (16.71B), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (13.75B), greater than Beijing Aosaikang Pharmaceutical Co., Ltd. (14.47B), greater than Guangdong Zhongsheng Pharmaceutical Co., Ltd. (17.31B), greater than Apeloa Pharmaceutical Co.,Ltd (17.91B), greater than Joincare Pharmaceutical Group Industry Co.,Ltd. (14.73B), greater than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (15.95B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 17.92B | $17.02B | |
| 14.46B | $14.27B | |
| 18.13B | $19.14B | |
| 16.71B | $18.12B | |
| 13.75B | $16.12B | |
| 14.47B | $15.81B | |
| 17.31B | $17.69B | |
| 17.91B | $18.47B | |
| 14.73B | $22.83B | |
| 15.95B | $14.68B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hybio Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hybio Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Hybio Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Hybio Pharmaceutical Co., Ltd. (300199.SZ)?
What is the 3-year average Enterprise Value for Hybio Pharmaceutical Co., Ltd. (300199.SZ)?
What is the 5-year average Enterprise Value for Hybio Pharmaceutical Co., Ltd. (300199.SZ)?
How does the current Enterprise Value for Hybio Pharmaceutical Co., Ltd. (300199.SZ) compare to its historical average?